Post Categories
Could FDA’s Expedited IND Pilot Create a Faster Path to First-in-Human Trials?
September 9, 2026
Moving a promising drug candidate from the laboratory into its first human study can require years of preparation. The US Food and Drug Administration…
Stopping Genetic Expansion Could Transform Huntington’s Disease and More
August 31, 2026
For years, drug development for Huntington’s disease has focused on reducing the toxic huntingtin protein produced by the mutant HTT gene. That strategy remains…
Disarming the Gut Toxin Behind Colon Cancer
August 24, 2026
Colorectal cancer is a stealthy killer, causing as many as 900,000 deaths each year, per the most recent World Health Organization data. As the…
Beyond the Buzz: How Coffee Contributes to Healthy Aging
August 17, 2026
Coffee consumption has long been associated with a longer life and lower risk of chronic diseases, but the biological reasons behind those observations have…
New Study Targets Potentially Deadly Diarrhea
August 12, 2026
Digestive distress has dominated recent headlines, as a parasite-driven cyclosporiasis outbreak continues to sicken thousands in North America. But recent research brings brighter news:…
The New Playbook for Psychedelic Drug Development
August 3, 2026
Psychedelic drugs may produce profound effects after only one or a few doses, but proving that those effects are safe, durable and clinically meaningful…
GLP-1 Drugs Might Stop Cancer in its Tracks
July 27, 2026
The use of GLP-1 receptor agonist drugs, or GLP-1s, has skyrocketed in recent years. A July 7 Gallup poll revealed that the percentage of…
The Microbiome’s Role in Combatting Alzheimer’s Disease
July 20, 2026
For decades, Alzheimer’s disease research has focused primarily on the brain. Amyloid plaques, tau tangles and neurodegeneration have dominated efforts to understand why memory…
The EU Approved a Combo Influenza/COVID Vaccine
July 13, 2026
The World Health Organization cites vaccine hesitancy, or the reluctance to receive vaccines, as a “growing challenge for countries seeking to close the immunization…
Leveraging COVID-19 Experience to Accelerate Vaccine Development
July 8, 2026
The rapid development of COVID-19 vaccines demonstrated what science can achieve under extraordinary pressure. It also exposed a persistent challenge in vaccine research: comparing…
mRNA Vaccines: Cancer, Autoimmune Disease, and Beyond
June 22, 2026
A single class of drug has the potential to treat infectious diseases, zoonotic diseases, autoimmune diseases, and even cancer. Messenger ribonucleic acid (mRNA) drugs…
SuperAgers Challenge Assumptions About Brain Aging
June 15, 2026
Memory loss is often viewed as an unavoidable consequence of aging. However, research published in Alzheimer’s & Dementia challenges that assumption by examining a group…
Could FDA’s Expedited IND Pilot Create a Faster Path to First-in-Human Trials?
September 9, 2026
Moving a promising drug candidate from the laboratory into its first human study can require years of preparation. The US Food and Drug Administration…
Stopping Genetic Expansion Could Transform Huntington’s Disease and More
August 31, 2026
For years, drug development for Huntington’s disease has focused on reducing the toxic huntingtin protein produced by the mutant HTT gene. That strategy remains…
Disarming the Gut Toxin Behind Colon Cancer
August 24, 2026
Colorectal cancer is a stealthy killer, causing as many as 900,000 deaths each year, per the most recent World Health Organization data. As the…
Beyond the Buzz: How Coffee Contributes to Healthy Aging
August 17, 2026
Coffee consumption has long been associated with a longer life and lower risk of chronic diseases, but the biological reasons behind those observations have…
New Study Targets Potentially Deadly Diarrhea
August 12, 2026
Digestive distress has dominated recent headlines, as a parasite-driven cyclosporiasis outbreak continues to sicken thousands in North America. But recent research brings brighter news:…
The New Playbook for Psychedelic Drug Development
August 3, 2026
Psychedelic drugs may produce profound effects after only one or a few doses, but proving that those effects are safe, durable and clinically meaningful…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
GRONINGEN, Netherlands–(BUSINESS WIRE)–QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…